China’s Crypto Trading Surges to $86.4 Billion Despite Bitcoin Ban
An Industry report shows how the Stock market crash and Evergrande housing crisis triggered increased cryptocurrency and Bitcoin trading within China.
Related Posts

Provisional 8th May 2024 FII net sold ₹ 6669cr DII net bought ₹5928 cr Provisional 8th May 2024 FII net sold ₹ 6669cr DII net bought ₹5928 cr
- Raj Gaurav Rai
- May 9, 2024
Provisional 8th May 2024 FII net sold ₹ 6669cr DII net bought ₹5928 cr Provisional 8th May 2024 FII net sold ₹ 6669cr DII net […]
M&M 1960 CE AT =66 CMP= 61 SL =55 Lot = 350 Trgt=68/70/72++++ BRITANNIA 4900 CE AT = 95 CMP= 89 SL =80 Lot = 200 Trgt=99/103/107++++ CIPLA 1470 CE AT = 48 CMP= 45.60 SL =42 Lot = 650 Trgt=49/50/51++++ TATACOMM 2000 CE AT =76 CMP= 72.55 SL =68 Lot = 500 Trgt=78/80/82++++ ASIANPAINT 2840 CE AT = 67 CMP= 61.5 SL =50 Lot = 200 Trgt=71/75/79+++ INFY 1600 CE AT = 56 CMP= 51.95 SL = 47 Lot = 400 Trgt=58/60/62++++
- Raj Gaurav Rai
- March 7, 2024
M&M 1960 CE AT =66CMP= 61SL =55Lot = 350Trgt=68/70/72++++ BRITANNIA 4900 CE AT = 95CMP= 89SL =80Lot = 200Trgt=99/103/107++++ CIPLA 1470 CE AT […]
Aurobindo Pharma | USFDA Approval – Aurobindo Pharma Limited has received final approval from the USFDA to manufacture and market their version of Mometasone Furoate Monohydrate Nasal Spray, which is equivalent to Nasonex Nasal Spray. – This new product will be launched in the first quarter of fiscal year 2025, potentially opening up new revenue streams for the company
- Raj Gaurav Rai
- March 20, 2024
Aurobindo Pharma | USFDA Approval – Aurobindo Pharma Limited has received final approval from the USFDA to manufacture and market their version of Mometasone Furoate […]